7 research outputs found
Organic residue analysis of Egyptian votive mummies and their research potential
YesVast numbers of votive mummies were produced in Egypt during the Late Pharaonic, Ptolemaic, and Roman
periods. Although millions remain in situ, many were removed and have ultimately entered museum
collections around the world. There they have often languished as uncomfortable reminders of antiquarian
practices with little information available to enhance their value as artefacts worthy of conservation or
display. A multi-disciplinary research project, based at the University of Manchester, is currently
redressing these issues. One recent aspect of this work has been the characterization of natural products
employed in the mummification of votive bundles. Using gas chromatography–mass spectrometry and the
well-established biomarker approach, analysis of 24 samples from 17 mummy bundles has demonstrated
the presence of oils/fats, natural waxes, petroleum products, resinous exudates, and essential oils. These
results confirm the range of organic materials employed in embalming and augment our understanding of
the treatment of votives. In this first systematic initiative of its kind, initial findings point to possible trends in
body treatment practices in relation to chronology, geography, and changes in ideology which will be
investigated as the study progresses. Detailed knowledge of the substances used on individual bundles
has also served to enhance their value as display items and aid in their conservation.RCB is supported by a PhD studentship from the Art and Humanities Research Council (43019R00209). L.M. and S.A.W. are supported by a Leverhulme Trust Research Project Award (RPG-2013-143)
Epigenome-wide Association Study of Attention-Deficit/Hyperactivity Disorder Symptoms in Adults
Pathophysiology, epidemiology and therapy of agein
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future
Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older peopleY. Rolland, S. Czerwinski, G. Abellan Van Kan, J.E. Morley, M. Cesari, G. Onder, J. Woo, R. Baumgartner, F. Pillard, Y. Boirie, W.M.C. Chumlea, B. Vella